FITC-conjugated CD44 Antibody (IM7)
(Synonyms: CD44,CD44-FITC,IM7)FITC-conjugated CD44 Antibody (IM7) is a Rat-derived and FITC conjugated monoclonal antibody, targeting to CD44.
-
Host:
Rat
-
Isotype:
Rat IgG2b,κ
-
Application:
FC
-
Reactivity :
Mouse
-
Formulation:
Supplied in PBS (pH 7.2) containing 0.1% Proclin300 and protein stabilizer.
-
Conjugation:
FITC
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
Applications
| Application |
FC
FC: Flow Cytometry
|
|---|---|
| Dilution Ratio | 5 ul per 106 cells in a 100 µl suspension |
Product Details
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in PBS (pH 7.2) containing 0.1% Proclin300 and protein stabilizer.
-
Storage & Stability
Stored at 2-8°C for 1 year, protect from light, do not freeze.
-
Shipping
Shipping with blue ice.
Background
-
Function
CD44 is a hyaluronic acid receptor and cell adhesion molecule that plays a broad role in cell migration, immune cell activation, stem cell maintenance, and tumorigenesis. CD44 serves as both a key marker for memory T cells and a classic surface marker in research on mesenchymal stem cells and cancer stem cells.
-
Expression
Tissue_specificity:Protein levels were detected in fibroblasts and urine (PubMed:25326458, PubMed:36213313, PubMed:37453717) . Protein levels were also detected in the placenta (PubMed:32337544) . Isomer 10 (epithelial isomer) is expressed in epithelial cells and is highly expressed in cancer cells. Expression is suppressed in neuroblastoma cells. -
Isoforms & Post-Translational Modification
CD44 has 19 isomers: P16070-1: 81538 Da (predicted); P16070-2: 3327 Da (predicted); P16070-3: 77983 Da (predicted); P16070-4: 76612 Da (predicted); P16070-5: 80790 Da (predicted); P16070-6: 76705 Da (predicted); P16070-7: 78446 Da (predicted); P16070-8: 74388 Da (predicted); P16070-9: 74196 Da (predicted); P16070-10: 53411 Da (predicted); P16070-11: 46565 Da (predicted); P16070-12: 39416 Da (predicted); P16070-13: 46261 Da (predicted); P16070-14: 43169 Da (predicted); P16070-15: 32075 Da (predicted); P16070-16: 73150 Da (predicted); P16070-17: 75957 Da (predicted); P16070-18: 37278 Da (predicted); P16070-19: 15635 Da (predicted).
Proteolytically cleaved in the extracellular matrix by specific proteinases (possibly MMPs) in several cell lines and tumors;N-glycosylated;O-glycosylated; contains chondroitin sulfate glycans which can be more or less sulfated and whose number may affect the accessibility of specific proteinases to their cleavage site(s). It is uncertain if O-glycosylation occurs on Thr-637 or Thr-638;Phosphorylated; activation of PKC results in the dephosphorylation of Ser-706 (constitutive phosphorylation site), and the phosphorylation of Ser-672 -
Subunit
Interacts with PKN2. Interacts with HA, as well as other glycosaminoglycans, collagen, laminin, and fibronectin via its N-terminal segment. Interacts with UNC119. Interacts with PDPN (via extracellular domain); this interaction is required for PDPN-mediated directional migration and regulation of lamellipodia extension/stabilization during cell spreading and migration. Interacts with EGFR.
-
Synonyms
CD44,CD44-FITC,IM7
Documentation
Powered by Bioz
